Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Enochian Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q3 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 02/19/2025 | Q2 2024 | N/A | -$0.04 | N/A | N/A | $0 |
| 02/19/2025 | Q1 2024 | N/A | -$0.28 | N/A | N/A | $0 |
| 10/28/2024 | Q4 2023 | N/A | -$0.16 | N/A | N/A | $181.45 K |
| 08/20/2024 | Q3 2023 | N/A | -$0.16 | N/A | N/A | $0 |
| 12/30/2023 | Q2 2023 | N/A | -$0.07 | N/A | N/A | $0 |
| 09/29/2023 | Q1 2023 | N/A | -$0.14 | N/A | N/A | $0 |
| 06/29/2023 | Q4 2022 | N/A | -$0.36 | N/A | N/A | $0 |
| 03/30/2023 | Q3 2022 | N/A | -$0.08 | N/A | N/A | $0 |
| 12/30/2022 | Q2 2022 | N/A | -$0.08 | N/A | N/A | $0 |
| 09/29/2022 | Q1 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 06/28/2022 | Q4 2021 | N/A | -$1.70 | N/A | N/A | $0 |
| 03/29/2022 | Q3 2021 | N/A | -$0.12 | N/A | N/A | $0 |
| 12/29/2021 | Q2 2021 | N/A | -$0.13 | N/A | N/A | $0 |
| 09/28/2021 | Q1 2021 | N/A | -$0.20 | N/A | N/A | $0 |
| 06/30/2021 | Q4 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 03/31/2021 | Q3 2020 | N/A | -$0.09 | N/A | N/A | $0 |
| 12/31/2020 | Q2 2020 | N/A | -$0.06 | N/A | N/A | $0 |
| 09/30/2020 | Q1 2020 | N/A | -$0.05 | N/A | N/A | $0 |
| 06/30/2020 | Q4 2019 | N/A | $0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enochian Biosciences, Inc. Earnings: FAQ's
Enochian Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 8th, 2023 based offlast year's report dates.
The conference call for Enochian Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Enochian Biosciences, Inc.'s latest earnings report can be read online.
Enochian Biosciences, Inc. (:ENOB) has a recorded net income of $-80,650,172.Enochian Biosciences, Inc. has generated $-0.84 earnings per share over the last four quarters.
Enochian Biosciences, Inc. (:ENOB) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is -0.03.